Apellis enters collaboration with SFJ Pharmaceuticals for APL-2 in hematologic indications March 1, 2019
Lusutrombopag approved in Europe for the treatment of severe thrombocytopenia in adults with CLD Feb. 25, 2019
The European Commission grants approval for Besremi for the treatment of polycythemia vera Feb. 22, 2019
Afibromer shielded engineered allogeneic cells demonstrate safety and efficacy in hemophilia A model Feb. 19, 2019
RSS